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Campylobacter jejuni gastroenteritis is the most frequent organism associated with acute infectious diarrhea worldwide. The
clinical presentation involves fever, diarrhea, rigors, and myalgias. Other extraintestinal symptoms that have been described
involve delirium and other neurological complications, and the most well-known is Guillain-Barré, where there is cross-reactivity
between the gastrointestinal tract and the brain. Despite previously described multiple neurological complications, there is a lack
of clinical data on the association of Campylobacter-related gastroenteritis with acute encephalopathy in immunocompetent
patients. The type of population, immunocompetent stage, and unfamiliarity with the clinical presentation makes this a
challenging diagnosis for clinicians. We report a case of Campylobacter gastroenteritis associated with acute encephalopathy in an
immunocompetent patient.

1. Introduction
Campylobacter jejuni (C. jejuni) is the most frequent organism associated with acute bacterial gastroenteritis around
the world [1]. The high incidence of Campylobacter diarrhea,
as well as its duration and possible complications, makes it
highly important from a socioeconomic perspective [2]. It is
estimated to cause 1.3 million human illnesses every year
with 96 million cases in 2010 in the United States [3]. The
clinical presentation is characterized mainly by abdominal
pain and diarrhea. A prodrome phase characterized by fever,
rigors, myalgias, and occasional delirium has been described
[2]. The most well-known postinfectious neurological
complications are Guillain-Barré syndrome (GBS) and
Miller-Fisher syndrome (MFS) [4]. Furthermore, worldwide

the incidence is 1 to 2 in 100,000 and 1 to 2 in 1,000,000, for
GBS and MFS, respectively [5]. Nearly 30–40% of GBS
patients had C. jejuni infection 2 weeks prior to onset of
neurological symptoms [6]. Other less frequent neurological
complications include Bickerstaﬀ’s brainstem encephalitis,
acute transverse myelitis, and acute disseminated encephalomyelitis (ADEM) [4, 7–9]. We present a case of
Campylobacter gastroenteritis presenting with associated
encephalopathy in an immunocompetent patient.

2. Case
A twenty-ﬁve-year-old female with unremarkable past
medical history was brought to the emergency department
due to progressive altered mental status. Per family report,
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the patient was in her usual state of health until one week
before this admission when she started to experience abdominal pain and diarrhea. The patient’s mother described
episodes of anxiety and unusual behavior-associated confusion specially the day before admission.
On the day of admission, the patient sought medical
attention at an outpatient clinic. While in the oﬃce, she
became confused and later she experienced a witnessed
seizure. The patient received a dose of lorazepam prior to
arrival at the hospital. On arrival to the emergency department, she was found unresponsive with a Glasgow
Coma Scale of six. She was afebrile and tachycardic with a
heart rate of 115 beats per minute. The rest of her vital signs
were within normal limits.
Her physical exam was remarkable for generalized decreased muscle tone and no clear focal deﬁcits. The patient
was intubated for airway protection. She was given a loading
dose of levetiracetam and was admitted to the neurosciences
intensive care unit.
Her initial laboratory tests showed respiratory alkalosis
with an elevated white blood cell count at 11.6 th/μl with
76.5% of neutrophils. Her complete metabolic panel showed
hypokalemia. Her urine toxicology, serum alcohol levels,
and urine analysis were unremarkable. C-reactive protein
was 3.3 mg/dL, and her lactic acid was 1.2 mmol/L. Blood
tests are summarized in Table 1.
A brain computed tomography (CT) without contrast
showed slightly increased low density in the left occipital
white matter compared to the right which increased the
suspicion of posterior reversible encephalopathy syndrome
(PRES), and these images are shown in Figure 1. Herpes
simplex virus (HSV) encephalitis and autoimmune epilepsy
were also considered in the diﬀerential diagnosis. The brain
CT with perfusion was negative for stroke. Chest X-ray
showed atelectatic changes in the right upper lobe. A CT of
the abdomen and pelvis was negative for ovarian teratoma.
The patient was started on acyclovir for suspected herpetic
encephalitis.
A brain magnetic resonance (MRI) was negative for
ﬁndings supporting the diagnosis of PRES. The electroencephalogram showed no evidence of seizure activity or epileptiform discharges. Lumbar puncture was performed, and
the cerebrospinal ﬂuid (CSF) had a clear appearance. The
opening pressure was normal. The CSF glucose was elevated
at 91 units. The CSF white blood cell count was 3/μL. Further
studies on CSF for ruling out meningitis were done, and they
included Cryptococcus neoformans/gattii, Cytomegalovirus,
Enterovirus CSF, E. coli K1, Hemophilus inﬂuenzae, Human
Parechovirus, Listeria monocytogenes, Neisseria meningitidis,
Streptococcus agalactiae, Streptococcus pneumoniae, varicellazoster, and herpes simplex virus 1, 2, and 6, which were
negative; details are shown in Table 2.
The infectious disease team was consulted, and doxycycline was added due to the high prevalence of typhus in the
area. Febrile agglutinins, West Nile virus, and fungal serologies were also negative (Table 1).
CSF studies for autoimmune epilepsy, including
N-methyl-D-aspartate (NMDA) receptor antibodies, glutamic acid decarboxylase (GAD-65) antibodies, and voltage-
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gated potassium channel (VGKC) antibodies, were negative
for autoimmune epilepsy, the more detailed studies in Table 2.
Human immunodeﬁciency virus was negative. Autoimmune
panel was negative for antineutrophil cytoplasmic antibodies
(ANCAs), antinuclear antibody (ANA), and double stranded
DNA (dsDNA) antibodies.
Due to persistent diarrhea during the initial day of
admission, a gastrointestinal infectious panel was ordered
and was positive for C. jejuni (Table 3).
Based on the clinical scenario of a patient with extraintestinal complications of Campylobacter infection, it was
decided to start azithromycin 500 mg per mouth for at least
10 days. The patient showed signiﬁcant improvement after
the ﬁrst dose and recovered over the next few days prior to
discharge.

3. Discussion
We are describing a case of Campylobacter jejuni gastroenteritis associated with acute encephalopathy in an immunocompetent adult. The complex initial presentation
with neurological symptoms makes this clinical scenario a
diagnostic challenge due to the unfamiliarity of clinicians
with this disease.
Campylobacter species belongs to a distinct group of
specialized Gram-negative bacteria designated as rRNA
superfamily VI [10]. The most important species that can
cause human disease are C. jejuni and C. coli [11]. Campylobacters invade the intestinal epithelium using ﬂagella,
high molecular weight plasmids, superﬁcial adhesins, and
chemotactic factors [12].
Patients infected with C. jejuni gastroenteritis experience
acute watery or bloody diarrhea, fever, weight loss, and
cramps that last six days on average [11]. Besides the gastrointestinal local infection, Campylobacter species also can
cause a range of other clinical manifestations or postinfectious immune disorders [13].
While infection with C. jejuni can occur in patients of all
ages, this infection is more prevalent in toddlers and young
adults than in other age groups [14]. Despite most of the
neurologic complications associated with Campylobacter
enteritis have been historically linked to the pediatric
population, some of these manifestations have been also
described in adults [9].
Our patient had an unusual presentation of C. jejuni
gastroenteritis associated with acute encephalopathy. Based
on her initial symptoms, she was treated with acyclovir for
the suspicion of HSV encephalitis. Moreover, the combination of seizures in association with the abnormalities
noted in the mentioned neuroimaging raised the initial
suspicion for PRES and autoimmune epilepsy. These diagnoses were ruled out with a brain MRI and a CSF autoimmune panel, respectively [15–17].
Other autoimmune systemic diseases including lupus
and vasculitis were ruled out with negative ANCA, ANA,
and dsDNA. We also considered ADEM following a C. jejuni
gastroenteritis in our diﬀerential diagnosis. Nonetheless, the
MRI did not show increased T2-signal intensity in the white
matter which is a characteristic neuroimaging ﬁnding in
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Table 1: Blood studies.

Complete blood count

Complete metabolic panel

Coagulation studies

Others

Serology

Infectious studies

Blood analysis
White blood cell
Percent neutrophils
Percent lymphocytes
Percent monocytes
Percent eosinophils
Percent basophils
Percent immature granulocytes
Hemoglobin
Hematocrit
Mean corpuscular volume
Mean corpuscular hemoglobin
Mean corpuscular hemoglobin concentration
Platelet count
Red blood cell distribution width CV
Red blood cell distribution width SD
Sodium
Potassium
Chloride
Carbon dioxide
Creatinine
BUN
Calcium
Glucose
Ammonia
AST
ALT
Alkaline phosphatase
Albumin
Total bilirubin
PT
INR
PTT
Sedimentation rate
C-reactive protein
Lactic acid
Alcohol serum
Alcohol serum calculation
ANCA screen∗
dsDNA
Symphony ANA screen
Symphony ANA
Complement C3
Complement C4
HIV antibodies
Aspergillus ﬂavus antibody
Aspergillus niger antibody
Aspergillus fumigatus antibody
Coccidioides antibody
Histoplasma antibody
Blastomycosis antibody
Febrile agglutinin panel∗
Respiratory viral panel PCR∗

Result
11.6
76.5
17.7
5
0.2
0.3
0.3
12.6
36.8
87.4
29.9
34.2
212
12
38.6
136
3.3
105
23
0.7
12
8.8
119
30
17
15
73
4.1
0.3
12.9
1.11
22.8
46
3.3
1.2
<10.00
<0.01
Negative
1.5
0.1
0.2
156
26
Nonreactive
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative

Reference range
(4.8–10.9) th/μL
(49.0–77.6) %
(11.8–40.8) %
(3.70–11.80) %
(0–4.8) %
(0–1.3) %
(0–1) %
(10.8–14.7) gm/dL
(32.2–42.9) %
(84–96) fL
(28.3–32.3) pg
(29.58–33.75) gm/dL
(146–388) th/μL
(12.20–15.80) %
(38.93–51.44) fL
(132–143) mmol/L
(3.5–5.1) mmol/L
(98–107) mmol/L
(21–31) mmol/L
(0.6–1.2) mg/dL
(7–25) mg/dL
(8.6–10.3) mg/dL
(70–113) mg/dL
(16–53) umol/L
(13–39) IU/L
(7–52) IU/L
(34–104) IU/L
(3.7–4.9) gm/dL
(0.2–1.2) mg/dL
(10.6–13) second
(0.90–1.10) INR
(24–36.7) second
2–30 mm/hr
<1 mg/dL
(0.5–1.99) mmol/L
<10.00 mg/dL
<0.01 gm/dL
Negative
<10 IU/mL
<0.7 ratio
<0.7 ratio
(87–200) mg/dL
(19–52) mg/dL
Nonreactive
Negative
Negative
Negative
Negative
Negative
Negative
Negative
Negative

∗

ANCA screen: p-ANCA, c-ANCA, and atypical p-ANCA. ∗ Febrile agglutinin panel: P-OX19, POX2, P-OXK, and Brucella. ∗ Respiratory viral panel includes
adenovirus, coronavirus, inﬂuenza A, inﬂuenza B, human metapneumovirus, parainﬂuenza, respiratory syncytial virus, rhinovirus, Enterovirus, Bordetella
pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.

ADEM [4]. Furthermore, patients suﬀering ADEM only
improve with high-dose steroids that our patient never
received [4].

Based on Rio Grande Valley demographics with high
prevalence of murine typhus in the area, the patient was
treated empirically with doxycycline until her agglutinins
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Figure 1: CT head without contrast showing increased low density in the left occipital white matter.

Table 2: CSF studies.

General analysis

Infectious studies

Autoimmune studies

Variable
CSF appearance
CSF WBC
CSF RBC
CSF glucose
CSF total protein
CSF Cryptococcus neoformans/gattii antigen
CSF Cytomegalovirus
CSF Enterovirus
CSF Escherichia coli K1
CSF Hemophilus inﬂuenzae
CSF herpes simplex virus 1
CSF herpes simplex virus 2
CSF human herpes virus 6
CSF human Parechovirus
CSF Listeria monocytogenes
Neisseria meningitidis
Streptococcus agalactiae
Streptococcus pneumoniae
Varicella-zoster virus
CSF West Nile IgM
CSF culture
CSF VGKC antibody
CSF NMDA receptor antibody
CSF NMDAR1 antibody, CBA
CSF AMPAR1 antibody, CBA
CSF AMPAR2 antibody, CBA
GABABR antibody, CBA
LGI1 antibody, CBA
CASPR2 antibody, CBA
GAD-65

Result
Clear
3
0
91
26
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
<0.90
No growth
<20
Negative
Negative
Negative
Negative
Negative
Negative
Negative
<5

Reference range
Clear
0–5/μL
0/μL
40–70 mg/dL
15–45 mg/dL
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
<0.90
No growth
<20 pmol/L
Negative
Negative
Negative
Negative
Negative
Negative
Negative
<5 IU/mL

VGKC: voltage-gated potassium channel; NMDA: N-methyl-D-aspartate; AMPAR: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor;
GABA: gamma aminobutyric acid B receptor; LGI1: leucine-rich glioma-inactivated 1; CASPR2: contactin-associated protein 2; GAD: glutamic acid
decarboxylase.

Case Reports in Infectious Diseases

5
Table 3: Stool studies.

Gastrointestinal analysis

Variable
Campylobacter
Clostridium diﬃcile
Plesiomonas shigelloides
Salmonella
Yersinia enterocolitica
Vibrio
Vibrio cholerae
Enteroaggregative E. coli
Enteropathogenic E. coli
Enterotoxigenic E. coli
Shiga-like toxin-producing E. coli
E. coli O157
Shigella/enteroinvasive E. coli
Cryptosporidium
Cyclospora cayetanensis
Entamoeba histolytica
Giardia lamblia
Adenovirus
Astrovirus
Norovirus
Rotavirus
Sapovirus

were negative [18]. In this clinical case, the neurological and
gastrointestinal symptoms rapidly resolved once the patient
was started on azithromycin for Campylobacter gastroenteritis. Azithromycin is the antibiotic of choice, has good
coverage for Campylobacter jejuni, shortens the duration of
symptoms, and decreases resistance compared to ﬂuoroquinolones [19, 20].
At this present time, the exact pathophysiology of
Campylobacter gastroenteritis associated with encephalopathy is unknown, but it is possible that mechanisms involving antibody cross-reactivity may play a role [9]. For
example, it is well known that bidirectional signaling exists
between the gastrointestinal tract and the brain in GuillainBarré syndrome after a C. jejuni infection, where the outer
membrane structures of Campylobacter containing sialic
acid resemble those seen in the human gangliosides [9].This
brings the topic of gut-brain axis, which explains that everything is interconnected: the gut can inﬂuence the brain,
the brain can inﬂuence the gut, and they both can inﬂuence
and be inﬂuenced by the immune system [21].
There are only a few cases of Campylobacter gastroenteritis with encephalopathy in immunocompetent population, and one of them went through a similar analysis
process of diﬀerential diagnoses, obtained similar workup as
in our patient based on the neurological symptoms, age of
the patient, immunocompetent status, and severity of
symptoms onset, with clinical improvement after starting
antibiotics [9].
Due to the low prevalence of Campylobacter-associated
encephalopathy in adults, we do not recommend assuming
that mental status changes in a patient presenting with
Campylobacter gastroenteritis are necessarily associated with
the infection. A proper and well-directed workup should be
completed to rule out other more frequent and emergent

Result
Detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected

Reference range
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected
Not detected

neurological diseases such as bacterial meningitis or vascular
disease. We would recommend considering Campylobacterassociated encephalopathy in the diﬀerential diagnosis of
diarrhea associated with mental status changes.
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